0000929638-23-000407.txt : 20230213 0000929638-23-000407.hdr.sgml : 20230213 20230213162532 ACCESSION NUMBER: 0000929638-23-000407 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20230213 DATE AS OF CHANGE: 20230213 GROUP MEMBERS: JEFF EASTON GROUP MEMBERS: LIND GLOBAL PARTNERS LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INVIVO THERAPEUTICS HOLDINGS CORP. CENTRAL INDEX KEY: 0001292519 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-85686 FILM NUMBER: 23618880 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 EAST 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-863-5524 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 1400 EAST 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Design Source, Inc. DATE OF NAME CHANGE: 20040602 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Lind Global Macro Fund LP CENTRAL INDEX KEY: 0001773156 IRS NUMBER: 830854952 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 444 MADISON AVE, FLOOR 41 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-395-3931 MAIL ADDRESS: STREET 1: 444 MADISON AVE, FLOOR 41 CITY: NEW YORK STATE: NY ZIP: 10022 SC 13G/A 1 sc13ga.htm AMENDMENT NO. 3
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
  

 
SCHEDULE 13G
 
  
 
Under the Securities Exchange Act of 1934
 
  
 
(Amendment No. 3)*
  

 
InVivo Therapeutics Holdings Corp.
  
 
(Name of Issuer)
  

 
Common stock, par value $0.00001 per share.
  
 
(Title of Class of Securities)
  

 
46186M605
  
 
(CUSIP Number)
  

 
December 31, 2022
  
 
(Date of Event which Requires Filing of this Statement)
  


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[ ]            Rule 13d-1(b)
[x]            Rule 13d-1(c)
[ ]            Rule 13d-1(d)
___________________________________
*  The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)

Lind Global Macro Fund, LP
2
Check the Appropriate Box if a Member of a Group (See Instructions)
 
(a)            [ ]
 
(b)            [x]
3
SEC Use Only
4
Citizenship or Place of Organization.
 
Delaware
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
5  Sole Voting Power
 
128,321
6  Shared Voting Power
 
0
7  Sole Dispositive Power
 
128,321
8  Shared Dispositive Power
 
0
9
Aggregate Amount Beneficially Owned by Each Reporting Person
 
128,321(1)
10
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
11
Percent of Class Represented by Amount in Row (9)*
 
6.3%
12
Type of Reporting Person (See Instructions)

PN
(1) The reporting person’s ownership consists of (a) 2,801 common shares and (b) warrants to purchase 125,520 common shares (the “Warrants”).

1
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)

Lind Global Partners LLC
2
Check the Appropriate Box if a Member of a Group (See Instructions)
 
(a)            [ ]
 
(b)            [x]
3
SEC Use Only
4
Citizenship or Place of Organization.
 
Delaware

Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
5  Sole Voting Power
 
128,321
6  Shared Voting Power
 
0
7  Sole Dispositive Power
 
128,321
8  Shared Dispositive Power
 
0

9
Aggregate Amount Beneficially Owned by Each Reporting Person
 
128,321(1)
  
10
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
  
11
Percent of Class Represented by Amount in Row (9)*
 
6.3%
  
12
Type of Reporting Person (See Instructions)

OO
  
(1) The reporting person’s ownership consists of (a) 2,801 common shares and (b) 125,520 Warrants.

1
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
 
Jeff Easton
2
Check the Appropriate Box if a Member of a Group (See Instructions)
 
(a)            [ ]
 
(b)            [x]
3
SEC Use Only
4
Citizenship or Place of Organization.
 
United States

Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
5  Sole Voting Power
 
128,321
6  Shared Voting Power
 
0
7  Sole Dispositive Power
 
128,321
8  Shared Dispositive Power
 
0

9
Aggregate Amount Beneficially Owned by Each Reporting Person
 
128,321(1)
  
10
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
  
11
Percent of Class Represented by Amount in Row (9)*
 
6.3%
  
12
Type of Reporting Person (See Instructions)
 
IN
  
(1) The reporting person’s ownership consists of (a) 2,801 common shares and (b) 125,520 Warrants.

Item 1.
 
(a)
Name of Issuer
   
 
InVivo Therapeutics Holdings Corp.
 
 
(b)
Address of Issuer’s Principal Executive Offices
   
 
One Kendall Square, Suite B14402
Cambridge, MA 02139
 

Item 2.
 
(a)
Name of Person Filing
   
 
This amendment is filed by the following entities and individuals (collectively, referred to as the “Reporting Persons”):
 
•  Lind Global Macro Fund LP, a Delaware limited partnership;
•  Lind Global Partners LLC, a Delaware limited liability company; and
•  Jeff Easton, an individual and a citizen of the United States of America.
 
Lind Global Partners LLC, the general partner of Lind Global Macro Fund, LP, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Macro Fund, LP.
 
Jeff Easton, the managing member of Lind Global Partners LLC, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Macro Fund, LP.
 
 
(b)
Address of Principal Business Office or, if none, Residence
   
 
The address of the principal business office for each of the Reporting Persons is:
 
444 Madison Ave, Floor 41
New York, NY 10022
 
 
(c)
Citizenship
   
 
See Row 4 of cover page for each Reporting Person.
 
 
(d)
Title of Class of Securities
   
Common stock, par value $0.00001 per share
 
 
(e)
CUSIP Number
   
 
46186M605
Item 3.
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable.
Item 4.
Ownership
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 
(a)
Amount Beneficially Owned
   
 
 See Row 9 of cover page for each Reporting Person.
 
 
(b)
Percent of Class
   
 
See Row 11 of cover page for each Reporting Person.

 
(c)
Number of shares as to which such person has:
 
   
(i)
sole power to vote or to direct the vote
     

See Row 5 of cover page for each Reporting Person.
 
   
(ii)
shared power to vote or to direct the vote
     
 
See Row 6 of cover page for each Reporting Person.
 
   
(iii)
sole power to dispose or to direct the disposition of
     

See Row 7 of cover page for each Reporting Person.
 
   
(iv)
shared power to dispose or to direct the disposition of
     
 
See Row 8 of cover page for each Reporting Person.
 

Item 5.
Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

Item 6.
Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
Not applicable.
Item 8.
Identification and Classification of Members of the Group
Not Applicable.
Item 9.
Notice of Dissolution of Group
Not Applicable.
Item 10.
Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Exhibits
Exhibit
 
99.1
Joint Filing Agreement by and among the Reporting Persons
 
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
February 13, 2023
     
LIND GLOBAL MACRO FUND, LP
   
By:
 
Lind Global Partners LLC
 
 
its General Partner
   
By:
  
/s/ Jeff Easton
Name:
 
Jeff Easton
Title:
 
Managing Member
 
LIND GLOBAL PARTNERS LLC
   
By:
 
/s/ Jeff Easton
Name:
 
Jeff Easton
Title:
 
Managing Member
 
JEFF EASTON
 
/s/ Jeff Easton






















EX-99.1 2 exhibit99-1.htm JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS
Exhibit 99.1

JOINT FILING AGREEMENT
 
The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common stock, par value $0.00001 per share, of InVivo Therapeutics Holdings Corp. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
 
February 13, 2023
 
     
LIND GLOBAL MACRO FUND, LP
   
By:
 
Lind Global Partners LLC
 
 
its General Partner
   
By:
  
/s/ Jeff Easton
Name:
 
Jeff Easton
Title:
 
Managing Member
 
LIND GLOBAL PARTNERS LLC
   
By:
 
/s/ Jeff Easton
Name:
 
Jeff Easton
Title:
 
Managing Member
 
JEFF EASTON
 
/s/ Jeff Easton